日本産科婦人科学会雑誌
文字サイズ
第43巻 第8号 目次
表紙
目次
第44回総会ならびに学術講演会予告 (第3回)
第45回学術講演会特別講演演者の推薦
第45回学術講演会シンポジウム課題の決定ならびに担当希望者公募
第46回学術講演会シンポジウム課題公募
妊婦貧血の用語, 定義, 分類, 診断基準 (案)
35歳以上の初産婦を高年初産婦とする
臨床・研究遂行上倫理的に注意すべき事項に関する見解の一覧
投稿規定
ステロイド療法の発展と21世紀への展望
癌細胞の発生とプログレッション
感染症治療の理論的背景 : 抗菌薬投与理論を中心に
婦人科悪性腫瘍の集学的治療における放射線療法の意義
胎児の行動 (fetal behavior) : その基礎と臨床
胎児行動における中枢神経系制御機構の発達過程に関する総合的解析 (<シンポジウム>胎児の行動 (fetal behavior) : その基礎と臨床)
高次神経機構成熟との連関からみたヒト胎児の行動の発達過程に関する研究 (<シンポジウム>胎児の行動 (fetal behavior) : その基礎と臨床)
胎児wellbeingの臨床的評価への胎児行動応用の基礎的研究 : 特に胎児行動発現様式の解離(dissociation)について (<シンポジウム>胎児の行動 (fetal behavior) : その基礎と臨床)
胎動図を基盤とするヒト胎児胎動の様相とその発達の研究 (<シンポジウム>胎児の行動 (fetal behavior) : その基礎と臨床)
討論
腫瘍マーカーの現況と将来
卵巣機能調節機構
胎児病 : その診断と治療の進歩
Program of the 43rd Annual Scientific Meeting
1 Heterogeneous human papillomavirus types in female genital tract.
2 Unknown human papillomavirus (HPV) in uterine cervical lesinos.
3 Detection of Human papillomavirus DNA in adenocarcinoma and adenosquamous carcinoma of the uteirne cervix.
4 A clinicopathologic study on the relationship of human papillomavirus infection to squamous cell carcinoma of the vulva usuing polymerase chain reaction and in situ hybridization.
5 Human papilloma virus 16 and 18 infection in cytological normal cervices by PCR (Polymerase Chain Rection) method.
6 Detection of human papilloma virus in cervical carcinoma and cervical intraepithelial neoplasma by polymerase chain reaction.
7 The presence or absence of human papillomavirus type 16 subgenomic regions in neoplasia of the uterine cervix.
8 Analysis of HPV16 mRNA in cervical carcinomas and cervical intraepithelial neoplasias by polymerase chain reaction with reverse transcriptase reaction.
9 Detection of HPV types 16 and 18 early gene E7 messenger RNA in uterine cervical cancers by polymerase chain reaction.
10 Alterations of cytoskeleton in human papillomavirus type 16 E7 mediated transformation.
11 Significance of genes amplifications of oncogenes in development of cervical cancer affected by human papillomavirus.
12 EGFR/c-erb B gene amplification in cancer in cell lines derived from female genital organs and establishment of serum-free maintained cell line.
13 Study of relationship between oncogene and drug sensitivity of human gynecological cancer transplanted into nude mice.
14 In vitro studies on the expression of c-myc oncogene product in gynecological cultured cancer cells.
15 Detection of tumor suppressor gene p53 and HPV type 16 E6/E7 mRNA in the uterine cervical dysplasia.
16 Allelic losses and mutations of the p53 gene in human ovarian carcinoma and endometrial carcinoma.
17 Suppression of tumorigenic phenotypes of cervical cancer cell by introduction of wild type p53 gene.
18 Suppression of endometrial cancer cell phenotypes by the introduction of wild type p53.
19 Suppression of tumorigenicity by transfer of a normal chrmosome 3 or 11 into a cervical cancer cell line, SiHa.
20 Detection of Antitumor Cytokine Production by Lymph Node Lymphocytes (LNL) or Ascites Associated Macrophages (AAM) in vitro.
21 Tumorigenic capability and TNF susceptibility of Squamous cell carcinoma.
22 Detection of Human papillomavirus DNA and Antitumor effect of Cytokines on Cervical adenocarcinoma cell lines.
23 Effect of recombinant Granulocyte Stimulating Factor (rG-CSF) and recombinant Erythropoietin (rEPO) on the ploliferation of gynecological cultured tumor cells.
24 Modulation of the immune response to transplanted tumors in rats by selective depletion of neutrophils in vivo using a monoclonal antibody
25 The expression of Mn-superoxide dismutase in human cancer cell lines after tumor necrosis factor-α treatment.
26 Evaluation of Cell Proliferative Activity after Irradiation Using Immunohistochemical Approach and Flow Cytometory.
27 Transition of growth fractions of carcinoma of the uterine cervix during radiotherapy and their association with radiation sensitivity.
28 Growth potential examined by the monoclonal antibody Ki-67 in cervical cancer and its relation to the clinical stage, histological type and the effects of irradiation.
29 Analysis of EGF-receptors and effects of EGF on growth of cancer cell lines originating from female genital organs.
30 Immunohistochemical study of the mucosal immune response persistent dysplasia of the uterine cervix.
31 Tissue plasminogen activator and urokinase in uterine cervical cancer.
32 Silver-stained nucleolar organizer regions in gynecologic neoplasms and its clinical implication.
33 Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plaminogen activator (pro-uPA).
34 A novel tumor-associated protein : clinical significance of serum levels in various clinical conditions with special reference to gynecological malignant diseases.
35 Interdisciprinary Combined Treatment of Gynecological Malignant Tumors : Combination with Intraarterial and Local Administration of CDDP
36 Intra-arterial Infusion Chemotherapy with CDDP in the management of uterin cervical cancer.
37 Advantage of intra-arterial CDDP infusion with venous hemodialysis as regards perfused tissue concentration.
38 A Study on the optimal placement of the catheter and the effects of angiotensin II during arterial infusion in treating gynecological malignant tumors : A nuclear medicine evaluation of intra-tumor blood flow using 81^mKr
39 The trial of intralymphatic administration of CDDP-LUF suspension for gynecological cancers.
40 Extension of cervical carcinoma in the parametrial ligament.
41 Comparison of CPL classification with tumor dissociation on spreading front of the uterine cervical cancer
42 A clinicopathological study of primary adenocarcinoma of the uterine cervix (531 cases) : biological behavior
43 Management of cervical dysplasia and carcinoma associated with pregnancy.
44 A combination chemotherapy consisting of 5-Fluorouracil, Doxorubicin, Cyclophosphamide, and Vincristine for Advanced or Recurrent Squamous Cell Carcinoma of the Uterine Cervix
45 Treatment of advanced or recurrent cervical cancer by a new "BOMP" Regimen consisting if bleomycin, vincristine, mitomycin-C, and cisplatin.
46 The effect of chemotherapy for cervical adenocarcinoma received radical hysterectomy.
47 Basic Study on Plasmapheresis Using a New Adsorptive Column : Improvement of Cancer Cachexic Condition.
48 Examination of conservative treatment in patient with juvenile uterine cervical cancer.
49 Study on the long term prognosis of cervical cancer.
50 Adenocarcinoma of the uterine cervix : a clinico-pathological study in 155 cases.
51 X-ray Computed Tomography in the Evaluation of Prognosis of Cervical Carcinoma.
52 Studies of postperative disorders and prognosis for pre and postoperative irradiation in uterine cervical cancer.
53 Reappraisal of cardinal ligament in radical hysterectomy.
54 Effect of IL-1 on Glycogen Content in Endometrial Cells.
55 Effect of dietary supplementation with eicosapentaenoic acid on surgically induced endometriosis in the rabbit.
56 Hysteroscopic evaluation of endometrium before IVF-ET.
57 An embryo-suppressing factor in endometriosis peritoneal fluid : measurement of its potency and correlation with clinical parameters.
58 Effect of minimal endometriosis on fertility.
59 Effects of the removal of menstrual endometrium in IVF.
60 Efficacy of AIH timed around 40 hours after the hCG injection, in hMG stimulated cycles.
61 Prelimanary results on hysteroscopic gamete intrafallopian transfer (GIFT), pronuclear stage tubal transfer (PROST) and tubal embryo stage transfer (TEST).
62 Evaluation of pregnancy rates within sperm preparation using various washing technique, and a randomized controlled analysis of PSRT.
63 Analysis of sperm transport with infertile patients with AIH-failure.
64 Studies on changes of number of motile sperm in the oviduct relative to time after various artificial inseminations (AI).
65 Predictive value of hormonal profiles in early stimulation cycle of in vitro fertilization and embryo trasfer
66 The effect of combination treatment of GnRH agonist and pure FSH for ovulation induction in patients with polycystic ovary syndrome.
67 The Relationship Between Day of Initial Estradiol Rise and Results of In Vitro Fertilization and Embryo Transfer Cycles Stimulated With GnRha-hMG-hCG.
68 Analysis of hormonal data in the cycle with the adjuvant use of GnRH analog (GnRHa) for IVF-ET and GIFT programs.
69 Important hormonal factors which suggest pregnancy in GnRH analogue/HMG-stimulated IVF cycles.
70 Improving fertilization rate in vitro of male factor patients by Zona opening methods with microhooks.
71 Cleavage of rabbit eggs after microsurgical injection of testicular spermatozoa.
72 The methods of preservation in mammalian's sperm nuclei.
73 Observation of localization of fibronection in the surface on human spermatozoa and its function.
74 The test for the sperm fertile capacity using Sperm Persistent Motility after 24 hours (SPM-24).
75 Chymotripsin treatment enhances fertilization in in vitro fertilization
76 The evaluation of the fertilizing capacity of human sperm by hemizona assay.
77 A NEW CRITERION FOR ASSESSING SPERM FERTILIZING ABILITY USING A COMPUTERIZED SEMEN ANALYZER, HT-M 2030.
78 The factors associated with fertilization capacity of epididymal spermatozoa in the patients with obstructive azoospermia.
79 Sperm Survival Test (SST) : Prediction of the fertilization rates (FR) in In Vitro Fertilization (IVF).
80 Effect of platelet activating factor on human spermatozoa penetration assay and the acrosome reaction.
81 Monozygotic twin formation in mouse embryos follwing fertilization in vitro.
82 The growth and development of the children born after in vitro fertilization (IVF).
83 Factors inducing the mouse polyploidy embryo after in vitro fertilization.
84 Results of IVF-ET by transfer of embryos on the next day aftsr oocyte retrieval.
85 The prognostic evaluation in detection of appearance of gestational sac and fetal heart movement following success of in vitro fertilization-embryo transfer.
86 Results of in vitro fertilization-embryo transfer on outpatient bases : comparison of three protocoles for time of embryo transfer.
87 Spontaneous abortion after In Vitro Fertilization-Embryo Transfer (IVF-ET) and its related factors.
88 Studies of glucose metabolism in preimplantation mouse embryo with microdetermination methods.
89 Inhibitory effect of Epidermal Growth Factor (EGF) on the preimplantation development of mouse embryos.
90 The mechanism of the effect of human oviductal cells on mouse 2 cell embryo development.
91 Effects of high osmotic sucrose medium on embryo growth and on embryo glucose metabolism.
92 Analysis of the uterine environment on mouse embryo development.
93 Blastocyst formation in vitro of hamster embryos cultured from single cell stage.
94 Cryopreservation of mouse embryos : slow versus ultrarapid freezing.
95 Fluctuations in the Blood Prolactin Levels and TRH Loading Test Classified According to Ovarian Stimulation Methods in in Vitro Fertilization and Embryo Trasfer
96 Dose progesterone (P) rise during ovarian hyperstimulation with or without combined GnRH analog influence the outcome of in vitro fertilization?
97 Measurements of kinin kallikrein levels and coagulo-fibrinolytic activities in the case of ovarian hyperstimulation syndrome (OHSS).
98 The mechanism of infertility in superovulated adult rats.
99 Implication of kinin-kallikrein (K-K) system in the pathogenesis of ovarian hyperstimulation syndrome(OHSS).
100 Development of a new method for the ovulation induction using pure FSH from the early stage f the menstrual cycles.
101 Dermal and suppository absorption of estrogen and danazole.
102 Interleukin-1β and prostaglandins in human follicular fluids.
103 HUMAN TROPHOBLAST CELLS IN VITRO
104 Effects of fibrinolytic system during use of oral contraceptives.
105 Midluteal phase progesterone/estradiol ratio in conceptional cycle and its change by various methods of ovulation induction.
106 Isolation efficacy of hydrophobic chromatography for the purification of early pregnancy factor.
107 Regulatory factor of endometrial and decidual epidermal growth factor receptors.
108 The sonographic findings of early spontaneous abortuses with chromosome aberrations.
109 The number of ovulations newlywed women required to conceive a clinical pregnancy : A study on the efficiency of human reproduction
110 Change of pH and Ca at fertilization.
111 Effects of antiphospholipid antibodies on prostacyclin production by cultured human vascular endothelial cells.
112 Evaluation of teratological effects of drugs prescribed during pregnancy and its accuracy.
113 Significance of TAT on the anti-coagulant therapy to the pregnant woman in habitual abortion.
114 Role of Fibronectin receptor in the maintenance of pregnancy.
115 The role of Fibvonectin at Implantation of Mouse Embryo.
116 Thrombin-antithrombin III complex (TAT) chages due to normal pregnancy.
117 Fibrinolysis and pregnancy.
118 Recurrent spontaneous abortion (RSA) and antiphospholipid antibodies (APA) : with special referece to appearance of APA induced by immunotherapy with husband's lymphocytes.
119 The influence of sera on endothelial cells in pregnancy induced hypertension and pregnancy aggravated hypertension.
120 Increased red-cell Na-Li countertransport (CT) and thromboxane A_2 synthesis in primigravid women : possible early predictor(s) of pregnancy-induced hypertension (PIH)?
121 Effect of the maltose-heparin therapy on intrauterine growth retardation on pregnancy induced hypertension.
122 Effect of low dose aspirin on production of prostaglains and endotherin, on blood coagulation and hemodynamics in PIH high risk pregnant women.
123 Effect of pregnancy on rat carotid artery response to vasoactive amines.
124 Expression of liver angiotensinogen and kininogen mRNA in prengnant spontaneously hypertensive rat and the effect of sodium intake.
125 Levels of Tyrosine metabolites and Tryptopahn metabolites in maternal serum and cord serum.
126 Study of blood flow velocity waveforms in the uterine and umbilical arteries during angiotensin sensitivity test.
127 Hypocalciuria in women with preeclampsia.
128 Effects of a circulating factor of changes in intracellular inoized calcium concentration in pregnancy induced hypertension (PIH).
129 Morphological study on eary-onset pure type gestosis placenta and placental bed.
130 The clinical application of ABPM in obstetric patient.
131 Electron microscopic observations of renal biopsy materials in gestosis
132 Reassessment of the most appropriate gestational period for the glucose challenge test in order to screen glucose intolerance during pregnancy.
133 The management for infant of mother with abnormal glucose tolerance to prevent neonatal hypoglycemia.
134 A STUDY ON THE EFFECT OF HYPOGLYCEMIA ON EARLY EMBRYOGENESIS USING WHOLE EMBRYO CULTURE SYSTEM
135 Evaluation of the validity of the diagnostic criteria of gestational diabetes in Japan.
136 Microglucoseuria, microalbuminuria, urinary β_2-microglobulin (BMG) and N-acetyl-β-glucosaminidase (NAG) during gestation and of relationship to the diabetic nephropathy.
137 Decreased autophosphorylation of the insulin receptor-tyrosine kinase in rats at term gestation.
138 Investigation of plasma and amniotic fluid 1,5-Anhydroglucitol concentration during pregnancy.
139 The change of plasma level of vasoactive prostanoids in patients with GDM.
140 A study on serum levels of 1,5-anhydro-D-glucitol in pregnant women concerning to obstetrical complications and neonatal outcome.
141 Serun apoproteins levels in normal and complicated pregnancy.
142 Plasma Zinc Coproporphyrin Determination at Delivery : New diagnosis method for amniotic fluid embolism.
143 Studies on fetomaternal management in pregnant women with SLE complications.
144 Relations between fetal growth, tord arterial blood flow, and histopathological finidings of the placental villi in pregnancy complicated by SLE.
145 hCG AS STIMULATOR FOR TRANCSIENT HYPERTHYROXIEMIA WITHIN EARLY GESTATION.
146 Benadrostin : an inhibitor of poly (ADP-ribose) polymelase : its bloking effect on abortion in SLE prone MRL/1pr mice.
147 Localization of immunoreactivity for inhibin/activin subunits in human corpora lutea of pregnancy and placenta.
148 Studies on placental CRF.
149 Placental aromatase in various abnormal pregnancies, measured by ELISA.
150 Intracellular localization and physiolosical role of ATP-dependent protease in human placenta.
151 Gene expression of nerve growth factor in the human placenta using reverse transcription-polymerase chain reaction (RT-PCR).
152 Detection of platelet-activating factor (PAF) in amniotic fluid by a radioimmunoassay (RIA) method.
153 Superoxide anion increases intracellular pH, intracellular free calcium and arachidonate release in human amnion cells.
154 Platelet aggregation inhibiting activity of human placental villi.
155 Clinical Evaluation of the Effect of Placenta Exchoriativa on Perinatal Anomalies.
156 Sonographic detection of pathological hypertortion of umbirical cord by the "Pitch" of cord twisting
157 Effects of oxytocin antagonist (dTVT) on uterine contractions in pregnant rats.
158 Study of Ca store sites of human uterine smooth muscle using chemically skinned-fiber.
159 Effect of exogenous endotoxin on the uterine contraction in maternal goat.
160 Chronological changes in gap junction formation of the rat uterine circular muscles during in vitro experiments.
161 Newly developed distance fetal monitoring system.
162 CONSTRUCTION OF HOSPITAL PERINATAL INFORMATION SYSTEM WITH COMPUTERIZED MEDICAL RECORD SYSTEM AND HOSPITAL ORDER ENTRY SYSTEM.
163 Estimation of the Incidence and the Abortion Rate in Habitual Aborters.
164 Development of Perinatal Management System Using a Optical Memory Card.
165 Elucidation of intellectual information processing due to analysis of the relationship between the information and the recognition at perinatal outpatient clinic.
166 Doppler assessment of the middle cerebral artery blood flow in the fetal hydrocephalus
167 Evaluation of the Preload Condition of the Fetus Inferior Vena Caval Blood Flow Pattern.
168 Two dimension Doppler ultrasonographical evaluation of the renal artery in the fetuses with growth retardation and oligoamnios.
169 Middle cerebral artery blood flow velocity waveforms as a strong predictor of fetal distress in intrauterine growth retardaton.
170 Analysis of fetal blood flow waveforms in IUGR utilizing pulsed Doppler method during fetal distress.
171 Safety zone in mother and fetus with severe pregnancy induced hypertension under the treatment with antihypertensive drugs.
172 Detection of displacements in fetal cardiac wall
173 Study in the relation between spectral analysis on FHR signals and fetal movemnt.
174 The relationship between umbilical blood flow and Doppler velocity waveforms during fetal hypoxia in Shiba goat experiments.
175 Spectrum analysis of NST by maximum entropy method(MEM). : Differentiation of the resting phase and non-reactive pattern.
176 Power spectral density of fetal heart rate changes advanced with gestational age in case of various time-scalings of cardiogram.
177 Chage of feto-placental circulation during uterine contraction
178 A New Amnioscope by Using Image fiber with Fluorescent Technique.
179 Free radical formation by ultrasound.
180 The utility of Pulse Doppler method to determine the termination of high risk pregnancy with latent fetal distress.
181 Fetal portal vein velocity measured in utero by pulsed Doppler.
182 The relationship between Doppler velocity waveforms in uteroplacental circulation and the migration of trophoblasts into myometrium of placental bed.
183 Catecholamine levels and its correlation to blood gase in umbilical venous blood obtained by cordocentesis.
184 Study of the cause of perinatal intracraial hemorrhage : the effects of presentation on the fetal cerebral hemodynamics after the onset of labour pains.
185 Fetoplacental circulation in twin pregnancy.
186 Antenatal diagnosis of discordant twin by ultrasonography and velocimetry of umbilical artery.
187 Circulatory changes in isolated goat fetuses with umbilical arteriovenous ECMO.
188 A quantitative analysis of fetal cardiac dysfunction according new standard of sonographicaly estimated.
189 Echocardiographic assessment of fetal and neonatal systolic time intervals in normal vaginal delivery and elective Cesarean section groups.
190 Change of human fetal foramen ovale flow during feral breathing movements.
191 Evaluation of cardiac dysfunction in the human fetus.
192 Estimation of fetal blood gas level by the combined assessment of FHR monitoring, fetal behavior and resistant index of umbilical artery by Doppler.
193 The Significance of hypoxic stress as stimuli for erythroid production in the fetus.
194 The pitfall of FHR monitoring in asymmetrical IUGR. : Comparison with fetal blood gases and umbilical arterial blood flow velosity waveforms.
195 Effect of 24-hour hypoxic hypoxemia on fetal epinephrine (E), norepinephrine (NE) and vasopressin (V) concentrations in goat.
196 Effect of theophylline on hypoxic fetal breathing inhibition.
197 Continuous measurement of oxygen consumption in fetal brain during fetal asphyxia. : Using of experimetal fetal asphyxia model.
198 Biological significance of IGFBP-1 on fetal development in mice.
199 Increased epidermal growth factor(EGF) bindings to intra-uterine growth retardation rat liver
200 Fetal growth curve from birth weight and factors related to growth retardation of twin pregnancy.
201 Studies on a physiological role of epidermal growth factor (EGF) in the fetal growth of mice.
202 The clinical significance of vibroacoustic stimulation test (VAST) as a method of assessing cerebral cortical function.
203 The usefulness of lung area in the antenatal evaluation of fetal pulmonary hypoplasia.
204 Histological Abnormality of the ductus arteriosus in infants with intrauterine growth retardation.
205 Endothelin-1 levels in maternal and feto-placental circuration.
206 Response of fetal hypothalamo-pituitary-adrenal axis by maternal immobilization stress in late gestation of rats.
207 The effect of natriuretic peptide (ANP) on the fetal circulation and vasopressin (AVP) release.
208 Ultrasonic assessment of fetal urine production in normal and complicated pregnancies.
209 An immunohistochemical study on distribution of surfactant apoprotein in hypoplastic lung of nonimmunologic hydrops fetalis and other diseases.
210 Indication of extracorporeal membrane oxygenation (ECMO) for severe neonatal asphyxia with persistent pulmonary hypertention(PPHN) : hypocarbia and neurological outcome.
211 Effect of β_2-adrenergic agonist (ritodrine) on fetal hepatocyte proliferation in primary culture.
212 Effect of IGF-I on amino acid glucose transport by cultured trophoblast cells.
213 Effect of maternally administered magnesium sulfate on the neonate.
214 Adverse effect of l-methamphetamine upon development of explanted rat embrys
215 Inhibiting effects of Atrial Natriuretic Peptide(ANP) on the Progesterone secretion in rat.
216 The effect of interleukin-1, interleukin-2 on progesterone production of fetal membranes.
217 Detection of Progesterone Receptor Messenger Ribonucleic Acid in Rat Brain using Reverse Transcription-Polymerase Chain Reaction.
218 Partial Cloning of Rat Progesterone Receptor cDNA using Reverse Transcription-Polymerase Chain Reaction.
219 Effect of estrogen, pituitary gonadotropins and prolactin on immunohistochemical localization of inhibin subunits in the ovary of hypophysectomized female rats.
220 Ovarian inhibin expression and estrous cycle in the rat.
221 Changes of hypothalamic-pituitary-ovarian function after chronic long acting LH-RH agonist treatment in mature female rats.
222 Pituitary hormone response to TRH in secondary amenorrheic woman associated with simple weight loss.
223 Episodical human growth hormone secretion in women with nomal menstrual cycle.
224 Research on Serum Testosterone and Pituitary-Brainstem Function in Cases of Menstrual Abnormalities in Relation to Polycystic ovarian Disease.
225 Effect of ritodrine on plasma melatonin concentrations in woman.
226 Role of melatonin and sleep on the nocturnal prolactin rise.
227 Analysis of mechanism for interleukin-1 (IL-1) : induced hCG release by trophoblast
228 Diurnal and nocturnal secretion patterns of luteinizing hormonein women with hypothalamic 2nd Grade amenorrhea.
229 Nocturnal LH pulsatile secretion in adolescent patients with hypothalamic amenorrhea.
230 Growth inhibition of MCF-7 human breat cancercells by aromatase inhibitors.
231 A study of endothelin-1 release from human decidual cells in early pregnancy.
232 Cloning and sequencing of human LH/hCG receptor cDNA.
233 Basic fibroblast growth factor (bFGF) in the neoplasia of the human ovary and uterus.
234 Expression of the prostaglandin H_2 synthase m-RNA in tissue with or without endometriosis.
235 Regulation of the secretion of tissue-type plasminogen activator(t-PA) in human endometrium.
236 Cellular mechaism of effects on steroidogenesis by endothelin-1 in cultured porcine granulosa cells.
237 The autocrine regulatory effects of basic fibroblast growth factor in rat granulosa cells.
238 Autocrine regulation of proliferation and differentiation of porcine granulosa cells by epidermal growth factor.
239 Cellular interaction between granulosa and theca cells in vitro by collagen gel culture method.
240 Interactions between cytokines and growth factors on growth of cultured porcine granulosa cells.
241 Changes of the plasma membrane fluidity of granulsa cells during the prosess of luteinization.
242 Effect of Activin A on humam granulosa luteal cell culture
243 Evidence for tight coupling of gonadotropin-releasing hormone receptor occupancy to stimulated phosphoinositide turnover and anti-gonado- tropin action in granulosa cells .
244 A study on chemotaxis movements of fertilized ova for Laminine pentapeptide in rats.
245 Physiologically Significant Inhibitory Hypothalamic Action of Substance P on Prolaction Release in the male rat.
246 Effects of intracellular Ca^<2+> and C-kinase on prolactin release from human decidual cells in early pregnancy.
247 Effects of Adenosie Human Decidual Prolactin (PRL) Production
248 Impaired suckling-induced prolactin secretion in steptozotocin-induced diabetic rats.
249 Tumor necrosis factor-α increases release of arachidonate and prolactin from rat anterior pituitary cells.
250 Studies on effect of thyroid hormone and epidermal growth factor on the human cytotrophoblast (C-cell).
251 Roles of disulfide bonds in β subnit of human chorionic gonadotropin (hCG) on immunological and biological activities of hCG.
252 Ascorbic Acid (AA) stimulates placental hormone secretion by choriocarcinoma cell line in Vitro.
253 Retinoic Acid (RA) stimulates hCG-α subunit secretion by choriocarcinoma cells in Vitro.
254 Molecular cloning of the cDNA for the human placental oxytocin like substance.
255 Regulation of ovarian oxytocin gene expression in bovine periovulatory phase.
256 Involvement of cyclic AMP on oocyte maturation in rabbits.
257 Effect of endothelin-1 and endothelin-3 on steroidog enesis by rat ovarian follicles and a proposal of ovarian ERAANPS.
258 Influence of progesterone on ovarian 15-HETE during ovulation in the gonadotropin-primed immature rat.
259 Hormonal regulation of gonadotropin receptor mRNA in rat ovary during follicular growth and luteinization.
260 The role Cu, Zn- and Mn-SOD in the rat and human ovary.
261 GONADOTROPIN INDUCES EXPRESSION OF C-FOS AND C-JUN GENES IN RAT OVARIES.
262 THE INVOLVEMENT OF PLATELET ACTIVATING FACTOR IN THROMBOCYTOPENIA AND FOLLICULAR RUPTURE DURING GONADOTROPIN-INDUCED SUPEROVULATION IN IMMATURE RAT.
263 Detection of gonadotropin-releasing hormone in the rat ovary : studies using the reverse transcription-polymerase chain reaction.
264 Inhibitory effect of catecholestrogens on ^<60>Co γ-ray radiation injury in mice.
265 Study of phenylethanolamine-N-methyltransferase (PNMT) activity and its localization in human myometrium.
266 Effects of ovarian steroids upon contractile responsiveness to adrenaline of the isolated guinea pig oviduct after bilateral ovariectomy.
267 Estrogen Binding Sites (E2R and E3R) in Cardiovascular System of rabbit.
268 Characteristics of nuclear steroid receptors in human ovarian endometriosis, adenomyosis and endometrim.
269 Lipid peroxides and E_2-17-Sulfate in pregnancy.
270 Significance of plasminogen activators in tissue to asses tumor characteristics in endometrial cancer.
271 Elevation of serum steroid sulfatase level in gynecologic cancers.
272 Immunohistochemical localization of basic ftoprotein in gynecological malignancy.
273 SCC antigen (SCC) expression in non-malignant lesions of squamous epithelium.
274 Analysis of the levels of Sialosyl-Tn antigen (S-Tn) in cervical mucus for a detection of cervical adenocarcioma.
275 Long-term effect of radiotherapy to uterine cervical cancer on lumbar bone mineral density (BMD).
276 Assessment of urinaty β-core fragment of hCG as a tumor marker of cervical cancer.
277 Magnetic resonance findings of uterine myomas : with reference to pathological findings.
278 MRimaging : Advanced uterine cancer after preoperative hypertensive intra-arterial chemotherapy
279 Role of MRI findings for evaluating spread of uterine cervical cancer.
280 Diagnosis of early malignant ovarian tumors by MRI plus CT.
281 Abnormal endometrial smear and plasma estradiol level in the endometrial hemorrhagic disease.
282 Flow cytometric study on DNA ploidy uterine endometrial cancer.
283 The estimation of collection method for endometrial smear of uterus.
284 The localization of intracellular fluoresein by Laser Scanning Micro scopy.
285 A pregnant case with cyclic neutropenia.
286 "Treatment and prevention of pulmonary thromboembolism occuring during pregnancy."
287 A case of HELLP syndrome with positive lupus anticoagulant.
288 A case of successful treatment with DDAVP in pregnancy with high dose γ-globulin therapy resistant ITP (idiopathic thrombocytopenic purpura) and MDS (myelodysplastic syndrome).
289 A case of pregnancy after Budd-Chiari syndrome.
290 CEA production of human ovarian cancer cell line.
291 The serum factor for secration of CA125 in ovarian cancer.
292 Analysis of the patients showing dissociation between serum CA125 and CA130 levels : consideration on the releasing mechanism of CA125 into the blood stream.
293 Relationship between immunohistochemical detection of P-glycoprotein and effect of chemotherapy in ovarian carcinoma.
294 Evidence for the involvement of TGFα/EGF receptor autocrine growth mechanism in a human ovarian cancer cell-line.
295 Flow Cytometric DNA Analysis Use of Normal Lymph Node Cells as an Internal Reference Standard in Ovarian Cancer
296 Increased sister chromatid exchanges of peripheral lymphocytes in patients with ovarian tumor.
297 Biological characteristics of ovarian immature teratoma (gene amplification, tumor marker, Chromosome, etc.).
298 Study of c-myc, c-hst, cfgr and c-ros-1 ooncoges amplification or rearrangement in human ovarian carcinomas.
299 p53 gene and ras oncogene expressions in human ovarian cancers.
300 Flow Cytometric Analysis of Cellular DNA Content in Epithelial Ovarian Cancer.
301 The existence of ovarian tumors with the mesonephric glomeruli as histogenetic precursors.
302 Characterization of three human ovarian cell carcinoma (OVISE) lines.
303 Amylase in Morgani's hydatid.
304 Study on estrogen production in parenchymatous cells of epithelial ovarian tumor.
305 Estrogen production in postmenopausal ovarian tumors.
306 Clinical significance of determination of serum manganese superoxide dismutase in ovarian carcinoma.
307 Establishment of human fibrosarcoma cell line of ovary and its chemosensitivity test for anti-cancer drugs.
308 Chemosensitivity test. : MTT agarose assay
309 Comparative study on subrenal capsule assay (SRCA) in vivo chemosensitivity tests against aniticancer agents to clinical response in donor patient.
310 Chemosensitivity testing of ovarian germinoma JOHYC-2 cell line by MTT assay.
311 Basic study on in vitro chemosensitivity tests.
312 A Study of the DNA ploidy and the chemosensitivity in the prognosis of ovarian cancer.
313 Estimation of anticancer agents to CDDP-resistant ovarian cancer cell line : single agent and combination chemotherapy.
314 Effects of Recombinant Human Granulocyte-Colony Stimulating Factor (G-CSF) and Erythropoietin (EPO) on Human Ovarian Cancer Cells in vitro.
315 Effects of FSH and Gonadotropin releasing hormone agonist (GNRHa) on ovarian cancer cell growth and invasiveness.
316 Anti-tumor effect of Gn-RH against DMBA-induced rat ovarian cancer.
317 Enhancement of anti-neoplastic effects of CDDP by inhibitors by PKC activity.
318 Basic and clinical studies on combined administration of Cisplatin and Etoposide in treating ovarian cancer.
319 Effect of CAP therapy on the prognosis of metastatic ovarian cancer.
320 Clinical evaluation of EAP (VP-16+ADM+CDDP) therapy in ovarian cancer : combination phase II study.
321 Chronic Daily Low-dose Administration of Oral Etoposide in Advanced Epitherial Ovarian Cancer.
322 Treatment results of PAI (cisplatin, adriamycin and ifosfamide) for stage Ic and IIc ovarian cancer.
323 Preventional effects of estrogen and vitamin D on lumber spine bone loss in postmenopausal women.
324 Decreasing the bone mineral content of the calcaneus in Japanese women by the effect of aging.
325 Effects of Ipriflavone administration on spinal bone mineral content and relation with lifestyle in patients after radical hysterectomy of uterine cancer.
326 Secondary osteoporosis due to radiotherapy : measurement by QCT and treatment by Alfacalcidol
327 Roles of cell growth factor and cytokines in postmenopausal osteoporosis.
328 Changes in bone mineral density determined by DEXA and bone metabolism in oophorectomized women : its longitudinal study.
329 Effects of ovarian function on bone mineral contents and parameters related to calcium metabolism.
330 Influence of oophorectomy on bone mineral status.
331 Effect of oophorectomy on serum levels of calcium regulating hormones.
332 Effect of long-term estrogen therapy on the lipoprotein metabolism.
333 Effect of estrogen derivatives on the proliferation of cultured aortic smooth muscle cells and their biosynthesis of collagen.
334 A study for the neuro-vascular (N.V.) mechanisms of Hot Flushes (H.F.) in climacterium assessed by the Acceleration Pletysmograph (A.P.) and Thermography (T.G.).
335 Influence of aging, lipoprotein metabolism and sex to muscle energy dynamics and endothelial cell function.
336 Mild hypertension in perimenopause.
337 Hormonal change of the climacteric hot flash.
338 Changes of adrenal function with age in ovariectomized women.
339 Characteristic of ovarian steroid enzyme activities in postmenopause
340 A preliminary open trial study of estrogen therapy for dementia of Alzheimer's type : Effects of estrogen on brain functions
341 Specificity of the steroid hormone metabolism in the ovary and adrenal gland with aging.
342 The changes of plasma levels of Insulin like growth factor-I in puberty in relation to growth and sex steroid.
343 Endocrinological study of amenorrhea associated with weight loss in young women.
344 Changes of blood leukotriene B4 and leukotriene C4 in patients with preterm labor.
345 Evaluation of chorioamnionitis and fetal infection by mesuring polymorphonuclear leucocyte elastase in the amniotic fluid.
346 In situ hybridization study of human parvovirus B19 in hydrops fetalis.
347 Actual state of rubella IgM test.
348 Change of human papilloma virus (HPV) DNA copy number during the course of the treatment for genital condyloma.
349 Antibiotic therapy against female genital tract infection with Chlamydia trachomatis
350 The Significance of Serum Antibody Titer in Infections with C. Trachomatis : With Special Reference to Pathologic Condition and Response to Therapy.
351 Clinical evaluation in patients with chlamydia trachomatis (CT) infection to the female genitalia and alteration of IgG and IgA titer with treatment.
352 Results of the pregnancy and parturition in mother with Chlamydia trachomatis antibodies.
353 New method for the detection of Chlamydia trachomatis infection and the serovar determination using polymerase chain reaction and dot-blot hybridization.
354 Vertical transmission of murine AIDS virus (LP-BR5 MuLV).
355 Vertical transmission of AIDS.
356 Anti C100-3 antibody and mother-to-infant transmission of hepatitis C virus.
357 The frequency of hepatitis C virus antibodies in pregnant women and possible transmission of hepatitis C virus.
358 Study of mother-to-child transmission of HTLV-I using the polymerase chain reaction.
359 Infection and antibody response in vertical transmission of HTLV-I in rabbits.
360 BIOLOGICAL ASSAY OF HTLV-I INFECTED PBLS IN ANTI-HTLV-I POSITIVE CARRIERS AND PROTECTIVE EFFECT ON HTLV-I INFECTION FROM CARRIER MOTHERS TO HER CHILDREN BY ARTIFICIAL NOURISHMENT OR FREEZE-THAWED BREAST MILK FEEDING.
361 Clinical study on risk of mother to child transmission of HTLV-1 by the mode of feeding.
362 HTLV-1 growth in cultual PBL and p40^ antibody titer in the serum as markers for the infectivity of HTLV-1 to infants borne by carrier mothers.
363 HTLV-1 familial clustering and significance of antibodies against p40^ Gene Product of HTLV-I.
364 Studies on ras oncogene activation in endometrial cancer.
365 Ras gene activation in neoplasms of the human female reproductive tract.
366 Detection of K-ras mutation and immunohistochemical investigation in endometrial adenocarcinomas and cervical adenocarcinomas.
367 Analysis of k-ras point mutation and T cell infiltration in endometrial cancer.
368 Detection of c-Ki-ras gene mutation in adenocarcinoma and hyperplasia of the uterine endometrium.
369 A transient decrease in N-myc expression and its biological role during differentiation of human embryonal carcinoma cells.
370 Alterations of cytoskeleton in human endometrial carcinome cells transferred by a chromosome #1.
371 Production of extracellular matrix components (ECMs) and expression of ECMs and cytoskeletons (CSs) in gynecologic tumor cell lines.
372 Human HHUA X normal fibroblast hybrids recover the tumor-forming ability by the loss of chromosome 4.
373 Loss of heterozygosity in endometrial carcinoma.
374 Differentiation of endometrial cancer cell line induced by M-CSF.
375 The presence of an endogenous inhibitor for estrogen receptor in human endometrium and endometrial cancer.
376 Zymographic Analysis of Colagenolytic Activity in Human Endometrial Carcinoma
377 The different expression of glycolipids in human endometrial adenocarcinomas with special reference to their differentiation.
378 An ultrastructural immunocytochemical study of endometrial adenocarcinomas using a monoclonal antibody MSN-1.
379 Significance of endometrial hyperplasia developing endometrial carcinoma.
380 Effectiveness of MPA and buthionie sulfoximine combination in chemotherapy of utrine endometrial cancer.
381 Differential effect of thermochemotherapy with medroxyprogesterone acetate in endometrial cancer.
382 Influence of hematological and coagular parametars during treatment of endometrial carcinoma with high-dose medroxyprogesteron acetate
383 Inhibitory effect of medroxyprogesterone acetate on angiogenesis induced by human endometrial cancer.
384 Effect of patient's serum on the endometrial clear cell carcinoma cell line.
385 The effect on cell cycle of two growth facters in human endometrial adenocarcinomas.
386 Characteristics of a new cell line (FU-MMT-2) established from a malignant mixed mullerian tumor of the uterus.
387 Flow-cytometric DNA analysis of uterine endometrial carcinoma, endometrial hyperplasia and normal endometrium.
388 Microcarcinomas and severe atypical focus of the endometrium.
389 Hitopathological study of adenosquamous carcinoma of the endometrium.
390 Paraaortic lymph node status in adenocarcinoma of the endometrium and its metastatic potential.
391 Major regional lymph nodes of ovary and corpus uteri, and the survey of lymph node metastasis of both ovarian cancer and endometrial cancer.
392 Paraaortic lymph node metastasis in gynecologic malignacies.
393 Evaluation of washing and/or ascites cytology in stage I・II endometrial cancers.
394 Role of MRI for evaluating the extent of endometrial carcinoma.
395 An analysis of the histopathologic factors of endometrial carcinoma.
396 A new combination chemotherapy for the refractory choricarcinoma.
397 Clinical evaluation of pathological choriocarcinoma patients treated in Kagoshima Municipal Hospital for 13 years.
398 Genetic identification of the responsible pregnancies for choriocarcinomas following multiple pregnancies by restriction fragment length polymorphism (RFLP) analysis.
399 Pregnancy outcomes after primary chemotherapy for trophoblastic disease.
400 Multidisciplinary treatment including hyperthermia for ovarian cancers.
401 Trial of CDDP-STS-Angiotensin II combination therapy in advanced and recurrent ovarian cancer.
402 The hypertensive effect induced with angiotensin II on the pharmacokinetic aspects and toxicities of CDDP during two-route chemotherapy using CDDP and STS.
403 High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) in patients with Stage III/IV ovarian cancer.
404 Long-term results of immunochemotherapy for advanced ovarian cancer.
405 Multidiscipliary treatment for ovarian cancers with liver metastasis : Chemotherapy with an intra-arterial infusion through the proximal brachial artery by a vascular access device (VAD).
406 Clinicopathological study of primary carcinoma of the fallopian tube.
407 The significance of purifying the retroperitoneal lymph nodes in early ovarian cancer : A study of Ia stage recurrent cases
408 Second (Third) cytoreductive surgery in recurrent cases of malignant ovarian tumor.
409 Prognostic variables in clinically NED patients with stage III and IV epithelial ovarian cancer.
410 Fertility preserving therapy in malignant ovarian tumors.
411 The significance of presurgical serum CA-125 levels in patients with primary epithelial ovarian cancer. : relationship to chlinical stage, histological type and tumor voulume
412 Early detection of ovarin cancer with transvaginal sonography.
413 The prognosis of ovarian cancer depends on the value of CA125 at the end of induction therapy.
414 Mass-screening methode for ovarian cancer by means of transvaginal ultrasonography : Study on size of ovary detected by ultrasonography, to select women needed to receive second screening.
415 Mass Screening for Ovarian Cancer by Transvaginal Ultrasonography.
416 The prevention stomatitis induced by anti-cancer drugs.
417 Mucinous Cystadenocarcinoma of the ovary in a 14 year old girl.
418 Case report : Sarcoma botrioides of the uterine cervix in the adolescent.
419 The use of a streptococcal BRM, OK-432, for treatment of desmoid tumor : a case report.
420 The use of activated carbon particle (CH44) for pelvic lymphadenectomy.
421 An application of new KTP/YAG laser in gynecological fields.
422 Comparison of cryosurgery and carbon dioxide laser therapy for CIN.
423 Perineo-ano-vulvectomy with lymphadenectomy and colostomy for carcinoma of the vulva.
424 Evaluation of laparoscopic multiple punch biopsies.
425 Transvaginal ultrasonographic findings of uterus and intrauterne cavity after one week from artificial termination of pregnancy.
426 The Usefulness of Transvaginal Puncture Alcohol (AL) Fixation Surgery in Treating Chocolate Cysts Follwing Endometriosis Conservative Surgery
427 The study on perioperative autologous blood transfusion for gynecological malignancies.
428 Management of intrauterine adhesions with hysteroscopic resectoscope.
429 Effect of taurine concentration in platelets on platelets ATP release induced ADP or collagen.
430 Leucocyte filterabilities in obstetrical & gynecological states of frequent occurrence of thrombosis.
431 IN VITRO effects of hypoxia on the deformability of erythrocytes.
432 Involvement of thrombin and cyclic AMP in the regulation of coagulation and fibrinolysis system of human trophoblasts.
433 Effect of Calphobindins on Procoagulant Activity on Human Endothelial Cells
434 Measurement of erythrocyte deformability by electron spin resonance (ESR) method, and its improvement by drug in pregnancy induced hypertension (PIH).
435 Study on the activation mechanism of platelet in toxemia of pregnancy, especially evaluation of the mobilization patter of the cytosolic free calcium stimulated by 5-HT and ADP.
436 The study about prediction of toxemia of pregnancy by urine level of plasmin-α_2 PI complex.
437 Hyperuricemia and hyperactivity of leukocytes in PIH cases.
438 Changes in the Coagulative and Fibrinolytic Systems and the Protective Mechanism against Peroxidation in Maternal and Umbilical Cord Blood in Patients with Severe Gestational Toxicosis.
439 Serum PAF-acetylhydrolase activity in normal pregnancy and EPH-gestosis.
440 Proliferative activity of human trophoblasts in term placenta as revealed by DNA cytofluorometry and Ki-67 immunohistochemistry.
441 The role of epidermal growth factor in the proliferation and differentiation of trophoblast.
442 Dipalmitoylphosphatidylcholine (L-α-lecithin) stimulates phospholipase A_2 activity in human amnion.
443 Effect of nifedipine on prostaglandin E_2 production in human amnion cells.
444 In-vitro prostaglandin release from isolated endometrial epithelial and stromal cells from rabbits of preimplantation period.
445 The significance of inflammatory markers for early detection of Chorioamnionitis on management of threatend preterm labor.
446 Luminol-dependent chemiluminescence (CL) of peripheral neutrophils in preterm labor.
447 Active Control of PROM under Gestational Week 27 by Warm Physiological Saline Filling Perfusion Therapy.
448 Experience with Perinatal Management of Prolapsed Fetal Membranes under 27 Weeks of Pregnancy by Cervical Cerclage with Bladder Overfilling and Decompression Combined.
449 Maternal complications, fetal-neonatal prognosis and placental pathology in singleton pregnancy, delivered between 24th - 31st week of gestation.
450 Clinical Pharmacokinetics of ritodrine hydrochloride following intravenous administration.
451 Lipid metabolism in IUGR neonate.
452 Study on tissue inhibitor of metalloproteinases (TIMP) during pregnancy and at delivery.
453 Analysis of organic acids in urine, serum and amniotic fluid of pregnant women.
454 Fatty acid composition in preterm infant.
455 Serum Seren, Superoxide dismutase, and Vitamine E in Pregnancy
456 Comparisons of glycosylated and nonglycosylated prolactin in milk and serum during the postpartum lactation.
457 QCT (Quantitative computed tomography) revealed the decreased bone mineral content (BMC) in postpartum primipara women.
458 The influence of noise stress on the suckling-induced oxytocin pulsatile release.
459 Changes of mRNA levels for prolactin receptor in the brain, liver, and, kidney of virgin, pregnant and lactating rats.
460 Calcium-regulating hormones and osteocalcin levels during pregnancy
461 Studies on the Bacteria from the cervical flora in the healthy pregnant women.
462 Analysis of urine protein for the prediction of preeclampsia
463 Glomerular size and charge selectivity of proteinuria and selectivity index in toxemia.
464 Evaluation of serum 1,5-anhydro-D-glucitol as a screening procedure for gestational diabetes mellitus.
465 Assessment of amniotic fluid volume by amniotic fluid index (four quadrant method) and relationship of oligohydramnios to perinatal morbidity.
466 The application for assessment of placental perfusion using digital subtraction angiography (DSA).
467 Embryonic heart activity : development in early pregnancy and clinical evaluation.
468 Simultaneous analysis of cell shape change and intracellular Ca^<2+> in human umbilical-vein endothelial cells.
469 Application of PCR to prenatal sex determination from maternal peripheral blood.
470 Transvaginal ultrasonic assessment of endometrial thickness and texture in spontaneous and stimulated cycles.
471 New method for prediction of fertility by transvaginal ultrasonography
472 The relationship between sperm-immobilization test and immunobead test.
473 A new simplified and highly sensitive reagent for measuring urinary luteinizing hormone.
474 Inhibition of sperm-zona pellucida tight binding by sperm-immobilizing antibodies (SI-Ab) as assessed by the hemizona assay (HZA).
475 Mouse pre-embryo survival after using different biopsy techniques : models for pre-embryo genetic diagnosis.
476 Restriction Fragment Length Polymorphisms Analysis of carrier determination of Duchenne muscular dystrophy in Japanese families.
477 Morphological Finding and Endocrinology of Lutal Phase Endometrium in Ovarian Hyperstimulation.
478 A Study on the Efficacy of Various Chemotherapies for Endometriosis Classified According to Region and Degree
479 Measurements of body fat and the evaluation of obesity by means of a near infrared spectroscopy and bioelectrical impedance analysis.
480 Histochemical application of keratan sulfate for the diagnosis of ectopic endometriosis.
481 THE SIGNIFICANCE OF INHIBIN ASSAY IN TROPHOBLASTIC DISEASE
482 Molecular heterogeneity of hCG in urine of patients with trophoblastic diseases.
483 The significance of measuring serum human chorionic gonadotropin(hCG) in the management with post molar patients.
484 Expression of P-glycoprotein in human placenta and hydatidiform mole
485 The function of Gp170, the multidrug resistance gene products, in human placenta villous membrane vesicles.
486 Evidence for a role of Plasminogen Activator and Plasmin in ovulation in in vitro perfused rat ovaries
487 Involvement of tyrosine phosphorylation in the regulation of mouse oocyte maturation.
488 Changes in structure and composition of glycolipids in human fallopian tube, endometrium, and cervical glands during the menstrual cycle.
489 Involvement of lipoxygenase pathway in the process of ovulation in rabbits.
490 Localization of extracellular matrix (ECM) on mouse embryos in immunohistochemistry.
491 Negative-charged Lipids in Rabbit Endometrium during the Implantation Period.
492 Ultrastructural studies of the interaction between epithelial and stromal cells in the human endometrium.
493 A Regulatory Mechanisms of Endometrial Epithelization after Menstrual Shedding.
494 Influence of sex steroid hormones on production of plasminogen activator and its inhibitor in human endometrial fibroblasts in vitro.
495 Biochemical and immunohistochemical investigation of glutathione peroxidase in normal, atrophic endometrium and endometrial carcinoma.
496 Immunoreactive endothelin-1 in human uterus.
497 Effects of steroid hormone on the activity of PLC and intracellular [Ca^<2+>] change stimulated by oxytocin.
498 Contractile response of the rabbit myometrium of adenosine 5'-triphosphate (ATP) : an analytical study on the contractile mechanism.
499 Alph-2 adrenoceptor on rat myometrium.
500 Contractile properties and cytoskeretal proteins of uterine smooth muscle cell during pregnancy in rats.
501 Analysis of 5HT and histamine-induced vasoconstrictor responses of isolated and perfused human umbilical arteries.
502 Effect of GnRH agonist leuprolide acetate depot on steroid receptors in leiomyoma and myometrium.
503 Concentration of Mn-SOD and Cu, Zn-SOD in peritoneal fluids of patients with endometriosis.
504 Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal tissues of the female genital tract and the placenta.
505 Immunohistological Study Of Endometriosis.
506 Endometrial antibodies in serum and peritoneal fluid of endometriosis patients.
507 Clinical significance of touch smear of products in cases of spontaneous abortion.
508 Monitoring of macrophage-colony stimulating factor (M-CSF) and granulo cytecolony stimulating factor (G-CSF) level of anmioic fluid.
509 Effect of macrophage-colony stimulating factor(M-CSF) on trophoblast cells.
510 The ultrastructural study of the transport of human prolactin across fetal term membrane.
511 Ultrastructural and histochemical observation on localization of neuroendocrine peptide in ovarian mucinous tumor.
512 The interactions of epithelial and mesenchymal cells are essential in the structuring and functioning of the ovarian follicular wall.
513 Effects of DHAS, estradiol, PGE2, and F2a on glycosaminoglycan production by uterine cervix fibroblasts.
514 Effects of DHAS, DHA and E_2 on the synthesis of Hyaluronic acid by human uterine cervical fibroblasts.
515 Derivation of lifespan extended cell line from the Simian Virus40 infected human uterine endocervical epithelial cells cultured on collagen gel.
516 Superoxide dismutase activity and lipid peroxide in the rabbit corpus luteum during pseudopregnancy.
517 The Role of active oxygen in the ovulatory process of rat.
518 Effect of macrophages on granulosa cell proliferation in rat.
519 Distribution of Ca^<2+>/calmodulin-dependent protein kinase II in the rat ovary.
520 Analysis of 3-0-sulfogalactose residue as an epitope of sperm immobilizing antibodies in sterile women's sera.
521 Identification of two human sperm antigens involved in immunologic infertility.
522 The effects of sperm immobilizing antibodies in sera of infertile women on Japanese monkey sperm.
523 Anti-idiotypic antibody (Ab2) against human monoclonal sperm immobilization antibody (Abl) for contraceptive vaccine.
524 Establishment of a transformat producing human sperm immobilizing antibodies on a large scale and constitutively using the cDNA expression vector.
525 Negativenly charged phospholipids as an corresponding epitope of sperm agglutinating monoclonal antibody.
526 Effect of monoclonal antibody to cardiolipin on murine pregnancy.
527 Increased expression of c-myc protooncogene in periperal lymphocytes in patients with preeclampsia.
528 Polyclonal activation of IgM antibodies to phospholipids in patients with idiopathic fetal growth retardation.
529 Studies on the compatibility in HLA-DQ gene locus in couples of unexplained habitual abortion analyzed by PCR-RFLP method.
530 Studies on the long term alteration of MLR-blocking factors (MLR-BF) in unexplained habitual aborters after immunotherapy with husband's lymphocytes. : good outcome of their second pregnancy with no therapy
531 Anti-phosphatidylethanolamine antibody (aPEA) and anti-cardiolipin antibody (ACA) in patients with recurrent fetal loss.
532 Immunological functions of human decidual macrophages in early spontaneous abortion.
533 Anti-Calphobindin-I auto-antibody in patients with recurrent abortions.
534 Binding of nuclear factors extracted from trophoblastic tumor cells to the regulatory elements of HLA class I gene.
535 Culture of trophoblast cells by growing chorionic villus explants and effect of the culture supernatants of trophoblast cells on lymphocytes proliferation.
536 Accumulation of CD16^-CD56^+natural killer cells with high affinity interleukin 2 receptors in human early pregnancy decidua.
537 Expression of functional high affinity interleukin-2 receptor on decidual CD56 positive lymphocytes.
538 Inhibitory effect of IL-1 on in vitro decidualization of human endometrial stromal cells.
539 The value of IL-1 α, β and IL-6 production in preterm infants and IL-6 concentration in amniotic fluid in the detection of infection.
540 Messenger RNA expression of Fcγ receptors involving their isoforms on human placenta.
541 The comparison of adult peripheral blood and cord blood for the unique lymphocyte subpopulations.
542 Two human monoclonal anti-cardiolipin antibodies derived from the same patient and their reactivity against endothelial cells.
543 Establishment of in vitro model for placenta with chorioamnionitis.
544 A Study on Usefulness of rG・CSF in Treating Bone Marrow Inhibition Arising from Chemotherapy in Ovarian Cancer Patients.
545 Effect of anti-CD3 antibody treatment and cryopreservation on the proliferating rate and anti-tumor activity of cultured tumor-infiltrating lymphocytes.
546 Suppressive mechanism of cytotoxic T lymphocyte induction and activation against autologous tumor cells.
547 The mechunisms of CTL generation to gynecology cancer cells with PBL.
548 Effects of antineoplastic prostaglandins on immune system.
549 Use of variable number of tandem repeat marker for the screening of polygene abnormality in congenital malformations.
550 A case of congenital cystic adenomatoid malformation (CCAM) with fetal hydrops.
551 A case report of a fetus with urethral obstruction at early gestation : The antenatal assessment of the fetal renal function was compared with the renal histological findings at autopsy.
552 Prenatal diagnosis of allantoic cyst.
553 Prenatal diagnosis with X-ray serial rotatosterography (SRG) : a case of holoprosencephaly.
554 Successful surgical management of fetal obstructive uropathy.
1 Detection of antibody against the human papillomavirus type 16 E7 protein in patients with gynecologic diseases.
2 Immunohistochemical study of c-myc and c-erbB-2 oncogene products in uterine cervical cancers.
3 Detection of human papillomavirus (HPV) in vulvar carcinoma and the related deseases by multitypes of HPV detectable PCR systems.
4 Immunohistochemical study of squamous cell carcinoma of the uterine cervix using keratin(56Kd and 68Kd) antibodies in different clinical stages.
5 Immunohistochemical study on the expression of carbohydrate antigens in uterine cervical carcinomas.
6 Immunohistological studies on the basement membrane and lymph node matastasis in endometrial carcinoma.
7 p53 gene expression in human uterine cervical cancer.
8 Detection of HPV in adenocarcinoma and glandular dysplasia of the uterine cervix using the polymerase chain rection.
9 Amplified DNA detection of Human Papillomavirus (HPV) types 16 and 18 E7 gene in cervical, vaginal and vulvar scrapes by polymerase chain reaction.
10 Flow cytometric analysis of DNA content in uterine cervical dysplasia.
11 Analysis of expression of c-myc and Ha-ras oncogenes in invasive cervical carcinoma.
12 Estimation of Medroxyprogesterone acetate against a human endometrial tumor constituted from the established Ishikawa cancer cells by a subrenal capsule assay.
13 An in vitro study on the temperature sensitivity of small cell carcinoma of the uterine cervix.
14 Synergistic enhancement of growth-promoting activity in extract from uterine cancers by phorbol ester and diacylglycerol through activation of protein kinase C in endometrial fibroblasts.
15 The relation between granulocyte elastase and urinary type plasminogen activator in uterine cervical cancer.
16 Morphological response of the regional lymph nodes in patients with cervical cancer and its immunological significance.
17 Effects of recombinant G-CSF on the growth of various cell lines derived from gynecologic tumors.
18 Effects of ginsenoside Rh_2 on human ovarian cancer cell proliferation in vitro and it's adjuvant effect to cisplatin in vivo.
19 Influence of sex steroid hormones on production of plasminogen activator and its inhibitor in newly established human ovarian cancer cell line (TC1989) in vitro and invasive cell growth.
21 Significance of thrombin・antithrombin III complex and plasmin・α2 plasmin inhibitor complex in gynecological cancer.
22 Establishment and characterization of a new mixed mesodermaal tumor cell lines of human uterus.
23 Examination of lymphoma-like lesion of the uterine cervix.
24 Histopathological study on parametrial spread of invasive carcinomas of the uterine cervix : with special reference to radical hysterectomy with preservasion of the pelvic autonomic nerve bundle
25 Reconstruction of surgical defect using the glutus maximus myocutaneous flap following radical vulvectomy.
26 Is it possible to omit diagnostic conization (cone) for cervical neoplasia with unsatisfactory colposcopic findings (UCF)?
27 Hysteroscopic evaluation of the therapeutic effect of medroxyprogesterone acetate on endometrial hyperplasia and cancer.
28 Valuablity of hysteroscopy for staging of endometrial cancer.
29 Altered expression of four carbohydrate antigens and CEA between primary and metastatic lesions of uterine cervical cancers.
30 Indication for preoperative hypertensive intra-arterial chemotherapy for cancer of corpus uteri.
31 Usefulness of implantable injection port for chemotherapy in patients with advanced gynecological carcinomas.
32 Concentration of CDDP in serum and tissues after intraarterial infusion.
33 Role of magnetic resonance imaging (MRI) for evaluating radiotherapeutic effect in patients with uterine cervical carcinoma.
34 Clinicopathologic study of mixed mullerian Tumor of the uterine corpus.
35 Relationship between endometrial metaplasia and carcinoma.
36 Sequential Intraperitoneal Chemotherapy to Induce Remission of Ovarian Cancer.
37 Influence factor of CA125.
38 Characterization of growth factor-like activities and fibrinolytic activity produced by human ovarian cancer cell lines.
39 Basic and clinical study on combination assay by using glycoprotein antibody in primary ovarian carcinoma.
40 RGD-containing peptide inhibits experimental peritoneal seeding of human ovarian cancer cells.
41 Abnormal processing of arylsulfatase A in ovarian cancer.
42 An in vitro Experimental Model for Cancer-Epithelial Surface Interaction Using Human Amnion.
43 A study on DNA leisons by cisplatin (CDDP) and its repair.
44 Alpha fetoprotein determinations in the management of yolk sac tumors of the ovary.
45 Growth of hydatidiform mole in immune-Deficient scid mice.
46 Oral contraceptives suppress the secretion of hCG like substance.
47 A case report of bilateral Krukenberg tumors of the ovaries metastatic from adenocarcinoma of the vermiform appendix.
48 A case of proved multiple bone marrow metastasis of a granulosa cell tumor 6 years after initial diagnosis.
49 Treatment of stage III endometrial cancer : A case report of neoadjuvant chemotherapy followed by radical hysterectomy.
50 Ovarian mature cystic teratoma with malignant transformation. 3 cases (Paget't desease, moderately differentiatded adenocarcinoma and mucoepidermoid carcinoma) report.
51 A new approach to the therapy for the advanced vulvar cancer : Novel method for local administration of high dose bleomvcin-polyacrylic acid natrium.
53 The Inhibitory Effect of 2-buten-4-olide, an Endogenous Feeding Suppressant, on Pulsatile Luteinizing Hormone Release.
54 Effect of growth hormone (GH) and placental lactogen (PL) on the regulatory mechanism of maternal serum Insulin-like growth factor 1 (IGF-1) concentration during pregnancy.
55 Purification of gonadotropes and intracellular free calcium oscillation : Effects of gonadotropin releasing hormone and interleukin 6.
56 Effects of saturated fatty acids on prostaglandin E_2 9-ketoreductase (PGE_2-9-KR).
57 Immunohistochemical analysis of progesterone receptor in human Fallopian tube.
58 Detection of PRmRNA in human uterus using RT-PCR.
59 Evaluation of oocyte maturation in terms of intracellular calcium oscillation at fertilization.
60 Hormonal profile in patients of threatened abortion with good outcome.
61 ^<31>P-NMR Spectroscopy stydy of the energy metabolism of perfused rabbit ovary in ovulation.
62 Studies on correlation between morphological changes of ovaries, androgen and obesity in polycystic ovariean disease.
63 On a cause of hyperprolactinemia in patients with PCOD.
64 Hyperlipidemia around menopause. : Effect of estrogen and HMG-CoA reductase inhibitor.
65 Menstrual abnormality, lumbago and bone minerals in young women.
66 Bone mineral density of lumbar and proximal femur in pre- and postmenopausal women.
67 Effect of ageing and castration on bone density in rats.
68 The effect of fat distribution on menstrual disorder in obese women.
69 Denervation of the rat myometrium during pregnancy.
70 The role of IL-6 in Human Milk.
71 OXT, PGE_2 and PGF_<2α> stimulate the generation of inositol phosphates in the myometrium.
72 Effect of sex steroids on cell differentiation and interleukin-1β production in the human promyelocytic leukemia cell line HL-60.
73 Immunohistochemical localization of estrogen receptors and progesterone receptors in the human fallopian tube, endometrium, and endocervix during the menstrual cycle.
74 The localization of granulocyte-colony stimulating factor (G-CSF) in human chorionic villi of normal placentas.
75 Stimulation of early embryonic development in the mouse by coculture with rabbit oviduct epitherial cells.
76 Prolactin inhibits plasmin activity in the preovulatory follicles in the preovulatory follicles in the ovulatory follicles.
77 Analysis of Proliferative potential of trophoblast Using anti-PCNA/cyclin Monoclonal Antibodies in Fixed, Embedded tissue.
78 Immunohistochemical analysis of Tcells and macrophages in first trimester human decidua.
79 Evaluation of Ethanol infusion therapy for Endometrial cysts.
80 Studies on the localization of adhesive proteins of the endometrium under various coditions.
81 A Computer Aided Analysis of the Three-dimensional Tissue Structure on The Invading Manner of Adenomyosis.
82 Relationship between the onset of dysmenorrhea and histological findings in adenomyosis.
83 Immunohistochemical study on distribution of E-cadherin in cervical cancer tissue and normal epithelial tissue in uterine cervix.
84 Evaluation of signal intensities of MRI on diagnosing the invasion of uterine endometrial carcinoma.
85 The value of histochemical analysis of Sialyl SSEA-1 antigen in patients with gynecologic tumors.
86 Urodynamic study of bladder dysfunction after therapy of uterine cancer.
87 Diagnostic criteria in MRI findings for myometrial invasion of endometrial cancer based on histopathological featurs
88 Study of detection of HPV infection and morphological findings in uterine cervix.
89 Basic and clinical evaluation of Gonal LH for prediction of ovulation.
90 Silver-stained nucleolar organizer regions (AgNORs) in the normal menstrual cycle using by cytlogical materials.
91 Diagnoses of ovarian tumors with MRI.
92 Evaluation of Fallopian Tube patency by Ultrasonography with Color Flow Imaging.
93 Immunohistochemical and serological investigation in internal and external endometriosis.
94 Significanse of the Screening with Urinary Sediments by IDEIA CHLAMYDIA on Chlamydial Infection in the Femal Urogenital Tracts.
95 Studies on the experimental Chlamydia trachomatis salpingitis in rabbits.
96 Management of Neonatal Herpes : In vitro assay (1).
97 Hepatitis C virus infection in gynecology. : Epidemiology and infection route.
98 Mother to child tranmission of HTLV-I detected by PCR and p40^ antibody.
99 Prevention of neonatal Group B streptococcal infection with intrapartum chemoprophylaxis.
100 Studies on the localization and the origin of the blood coagulation factor XIII subunit A (XIIIA) of the secretory phase endometrium and the placenta.
101 Clinical and basic study on coagulation and fibrinolysis system in Antiphospholipid antibodies pregnant women.
102 Ultrastructural localization of plasminogen activator inhibitor (PAI) within human pregnant tissues.
103 Blood coagulation and Spontaneous Abortion in Mice.
104 The KTP/532 Laser for Laparoscopic gynecologic surgery.
105 A case of pregnant woman complicated with myelodysplastic syndrome.
106 A case of diabetes insipidus occurring in early gestational stage.
107 Analysis of the deliveries.(cesarean section and transportation system) : A report of Iki island
108 A case report of malignant rhabdoid tumor associated with pregnancy.
109 Genetic analysis on an extremely rare case of sex differentiatiog anomaly.
110 Effects of transient hyperprolactinemia in In Vitro Fertilization and Embryo Transfer.
111 A fertilization blocking antibody which recognizes an antigen epitope of lysozyme in human spermatozoa.
112 Effect of clomiphene citrate on endometrial morphology.
113 Studies of serum hCG levels and prognosis of pregnant cases produced by IVF.
114 Effect of the surfactant like phospholipids in the tubal endothelial cell and their secretory products.
115 Effect of antiphospholipid autoantibodies on the results of in vitro fertilization.
116 The effect of antiphospholipid antibodies (APA) in the sera of women with unexplained recurrent spontaneous abortion (RSA) on trophoblast (Tr) cell proliferation.
117 The assessment of metabolic function of frozen/thawed embryos by ^<125>I-BSA uptake.
118 Effect of Co-culture on Development of Mouse Zygotes In Vitro.
119 Effects of assisted hatching at 2 cell stage on embryo growth.
120 Effects of coculture between early stage embryos and the cell of extra sexual oragan on embryo development.
121 The biological active substance produced by early embryo in preimplantation state.
122 Effect of oxidative stress on the whole mouse embryo culture.
123 Development of Mouse Early Embryos in CZB Medium.
124 Dual functions of Activin A in the Fertilization in Vitro in the mouse
125 Zona induced acrosome reaction of human spermatozoa and the influence of cervical mucus and cumulus oopholus on the acrosome reaction.
126 Evaluation of Hyposmotic Swelling Test (HOST) and Eosin-Y Supravital staining (EOY) as a method of examining sperm fertility potential (SEP).
127 Perinatal outcome after IVF-ET at Suzuki Hospital.
128 Evaluation of three-layer percoll gradient method for semen manipulation in IVF-ET.
129 Pregnancies after cryopreservation of the human embryo.
130 Micromanipulation of non-fertilized human oocytes in IVF-ET program.
131 Development of a Three Dimensional Color Doppler System.
132 Quasi real-time stereoscopic presentation of color flows in ultrasonography.
133 A study on bone mineral densisty (BMD) in pregnant women and postpartum women : the effect of long-term lactating.
134 Quantitative evaluation of fetal blood flow by the echotracking measurement of vessel diameter.
135 The relation between Intrauterine infection of the fetus and Pathological finding of the placenta and umbilical cord on Preterm PROM.
136 Estimation of daily energy expenditure during pregnancy by heart rate method.
137 Molecular Biological studies on Expression of Placental Alkaline Phosphatase.
138 The effect of 5-lipoxygenase product on PGI_2 production in guinea pig lung.
139 RELATIONSHIP BETWEEN FETAL HYPOXIA AND ENDOTHELIN-1 IN FETAL CIRCULATION.
140 Morphological and Functional Study of Rat Implantation Site.
141 THE SOURCE AND COMPOSITION OF ENDOTHELIN IN THE HUMAN AMNIOTIC FLUID.
142 Doubling times for serum hCG, hCGβ and SP1 during the first weeks of pregnancy.
143 Role of PVN oxytocin neurons on the onset of labor in rat.
144 Effect of the vascular endothelial cells on refractoriness to Angiotensin II (A-II) of pregnant and non-pregnant rabbits. : Significance of Nitric Oxide as EDRF
145 Treatment and fetal outcome of lupus anticoagulant-positive pregnancies.
146 Effects of Magnesium sulfate (MgSO_4) on the isolated uterine artery and platelets from pregnant women.
147 The change of venous tone in pregnancy induced hypertension and chronic hypertension complicating pregnancy.
148 Effects of ouabain on Na^+, K^+-ATPase activity, blood pressure, and vascular contractility.
149 Study of urinary calcium and phosphate excretion in patients with toxemia of pregnancy.
150 Urinary calcium excretion in pregnant women with pregnancy induced hypertension (PIH).
151 Effect of ritodrine hydrochloride on uterine and umbilical blood flow during pregnancy.
152 How should a pregnant woman do sports?
153 Assessment of cerebral hemodynamics in hypertensive pregnant women by Transcranial Doppler velocimetry.
154 Parmacokinetics of Vitamin K in Mothers and Chirdren in the Perinatal Period.
155 Correlation between the pattern of basal body temperature and serum progesterone-estradiol ratio at late pregnancy.
156 Estimation of smoking and passive smoking mothers by cotinine measurement and its effect on fetal growth and neonates.
157 Ovein Fetal and Maternal Glomeruli Atrial Natriuretic Peptide Receptors : Response to Dehydration.
158 Study on brain damage of the experimental grows-retarded rat fetus.
159 Alteration of cerebral blood flow in the fetal sheep measured by positron emission tomography during 10min sustained total asphyxia.
160 Morphometrical evaluation of the lung and liver in the cases associated with hyaline membrane desease.
161 The Maturational Process of Premature infants on Trendgram of Electroencephalogram.
162 Experimental pulmonary hypoplasia due to oligohydramnios : The influence of the time of onset and the duration of oligohydramnios.
163 Prediction of the prognosis in growth retardated fetus by Doppler ultrasound velocimetry.
164 Prenatal diagnosis of meningocele with hydrocephalic fetus.
165 Clinical significance and treatments of massive intervillous fibrin deposition(MIFD) associated with recurrent fetal growth retardation.
166 A Sonographic screening for chromosomally abnormal fetuses.
167 The clinical evaluation of the estimated prenatal growth curve in twin pregnancy.
168 Usefulness of cordocetesis for rapid karyotyping.
169 Prenatal diagnosis in 2293 amniocenteses.
栄養問題委員会報告 : 妊婦貧血の現状分析ならびに用語・診断基準に関する解説
会員入退会
学会研究会案内
7月受付原稿
裏表紙
CONTENTS
